Search PubMed⌕ Search

PubMed · 3883621

Current issues regarding posterior urethral valves.

Abstract

There are a number of factors that affect ureteral dilatation in patients with posterior urethral valves. These include large urinary outputs, a noncompliant bladder, and distal ureteric fibrosis. Dilatation alone does not imply obstruction, and careful studies should be obtained to document obstruction prior to considering any surgery. Our prejudice leads us to avoid ureteric reconstruction in the period immediately after valve ablation. Our findings suggest that these patients have hypertonic bladders immediately after valve ablation period, so it could be hazardous to reimplant the ureter in such a bladder and thereby expose these kidneys to unnecessary high pressures. Each patient with persistent dilatation should be treated on an individual basis. Some will require no treatment, some reimplantation with or without tailoring, and some an augmentation cystoplasty. More conservative approaches include double and triple voiding regimens, intermittent catheterization, anticholinergics, alpha sympathomimetic blockers, and regimens to decrease urinary output. These same regimens also seem to have a role in improving the level of continence, as does the onset of adolescence. Fortunately, the majority of patients with posterior urethral valves can be treated with valve ablation alone. Unfortunately, a number of patients who have creatinines of less than 1.0 mg per dl following treatment in the first year of life will go onto renal failure years later. Rapid progression to renal failure usually does not ensue until the teenage period, when proteinuria and hypertension seem to be the hallmarks. The progressive renal failure that develops in these patients may be related to the hyperfiltration syndrome that Brenner and Levine reported in patients with a decreased number of nephrons. A role for decreased intake of protein may have some influence in preserving the function of patients with a reduced number of nephrons and hopefully will affect the ultimate prognosis. The author anxiously awaits the formation and results of studies that will employ such a dietary regimen for patients with a history of severe valves in the hope of preserving renal function. However, such reports are not likely to be forthcoming during this decade.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K I Glassberg. 1985. Current issues regarding posterior urethral valves.. https://pubmed.ncbi.nlm.nih.gov/3883621/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

[Urinary infections in patients with urologic complications after kidney transplantation].

BACKGROUND: Urinary tract infections (UTI) are the most frequent infectious complications after renal transplantation (Tx). We tried to analyse whether the urinary tract infection was one of the factors which participated in the lower allograft survival rates and in the reduced allograft function in urologically complicated (UC) patients. METHODS AND RESULTS: We observed 77 patients after Tx whom 42 had urinary fistula, 32 had urinary tract dilatation a 3 suffered from both complications. They were observed from January 1992 through December 1999. 100 patients without urological complications represented a control group (N). Obtained data was statistically evaluated using t-test, chi 2-test, correlation analysis. Graft and patient survival rates were assessed using the Kaplan-Meier method. We have found that UC patients after Tx had worse renal function compared with patients not suffering from this complications. Using Kaplan-Meier methods we have found that graft survival rate in patients with UC is significantly lower than that in the control group (5-year graft survival 0.6 vs 0.82, p < 0.01). On the other hand there were no differences in the 5-year patients survival rate between the followed groups of patients (0.74 vs 0.83). There was no significant correlation between predicted creatinine clearance and followed indicators of UTI--total time of positive urine bacterial cultivation, number of infectious periods and total time of antibiotic therapy. There were no significant differences in graft survival during 5 years between patients with UTI and control group. CONCLUSIONS: Our results suggest that patients with UC are at increased risk of urinary tract infection. Our findings are in keeping with the assumption that UTI in patients with UC do not significantly participate in the decreased level of graft function and in the shorter graft survival rates.

Dilatation, Pathologic↗

Downsizing of voice prosthesis diameter in patients with laryngectomy: an in vitro study.

In patients with laryngectomy, voice prostheses inserted into a tracheoesophageal fistula (TEF) are widely used for vocal rehabilitation. Gradual dilation of the TEF may cause bothersome leakage around voice prostheses. Prosthesis-related weight and mechanical trauma possibly exacerbate TEF dilation. If prosthesis size were to be decreased, with a concomitant decrease in prosthesis weight and diameter, dilation of the TEF would probably lessen. We performed in vitro tests to study the effects on aerodynamic prosthesis function when the prosthesis size-in particular, the inner diameter-was decreased. The effects on airflow and pressure were specifically studied in the airflow range of patients with laryngectomy. A 1-mm decrease of the regular inner prosthesis diameter from 5 mm to 4 mm showed no significant aerodynamic consequences at the average laryngectomized airflow point. Also, such a 1-mm decrease in diameter involved a prosthesis weight reduction of 18%. In view of these findings, downsizing the standard prosthetic diameter should be considered in future voice prosthesis development.

Dilatation, Pathologic↗

Three-decade follow-up in pulmonary artery ectasia: risk assessment strategy.

We present a 29-year follow-up in a patient with ectasia of the pulmonary trunk and mild valvular stenosis. There was no progression from the first presentation at the age of 15 months until the actual age of 30 years, the z-value of the diameter of the pulmonary trunk remaining almost constant (z-value 22). This indicates that pulmonary dilatation with normal pressure may be a benign disease.

Dilatation, Pathologic↗